NCT03719586: A trial that was reported late by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported, although it was 112 days late in doing so.
Full data
Full entry on ClinicalTrials.gov | NCT03719586 |
---|---|
Title | A Multicenter, Multi-Outbreak, Randomized, Controlled Safety and Efficacy Study of Investigational Therapeutics for the Treatment of Patients With Ebola Virus Disease |
Results Status | Reported (late) |
ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
Start date | Nov. 21, 2018 |
Completion date | Sept. 9, 2019 |
Required reporting date | Sept. 8, 2020, midnight |
Actual reporting date | Dec. 30, 2020 |
Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
Days late | 112 |